These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Königsberg R, Obermayr E, Bises G, Pfeiler G, Gneist M, Wrba F, de Santis M, Zeillinger R, Hudec M, Dittrich C. Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508 [Abstract] [Full Text] [Related]
4. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy. Mikulová V, Cabiňaková M, Janatková I, Mestek O, Zima T, Tesařová P. Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991 [Abstract] [Full Text] [Related]
5. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer. Nam SJ, Yeo HY, Chang HJ, Kim BH, Hong EK, Park JW. Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142 [Abstract] [Full Text] [Related]
6. Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells. Nini A, Hoffmann MJ, Lampignano R, Große Siemer R, van Dalum G, Szarvas T, Cotarelo CL, Schulz WA, Niederacher D, Neubauer H, Stoecklein NH, Niegisch G. Cytometry B Clin Cytom; 2020 Jul; 98(4):355-367. PubMed ID: 32212383 [Abstract] [Full Text] [Related]
7. Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients. Kallergi G, Agelaki S, Papadaki MA, Nasias D, Matikas A, Mavroudis D, Georgoulias V. Breast Cancer Res; 2015 Aug 19; 17(1):113. PubMed ID: 26285572 [Abstract] [Full Text] [Related]
10. Detection of circulating tumor cells in metastatic breast cancer patients. Sanislo L, Vertakova-Krakovska B, Kuliffay P, Brtko J, Galbava A, Galbavy S. Endocr Regul; 2011 Jul 19; 45(3):113-24. PubMed ID: 21793623 [Abstract] [Full Text] [Related]
11. [Detection and clinical value of epithelial cellular adhesion molecule (EpCAM) mRNA positive circulating tumor cells in metastatic breast cancer]. Yan Y, Cheng JP, Di LJ, Song GH, Ren J. Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr 18; 44(2):275-80. PubMed ID: 22517003 [Abstract] [Full Text] [Related]
15. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients. Alunni-Fabbroni M, Majunke L, Trapp EK, Tzschaschel M, Mahner S, Fasching PA, Fehm T, Schneeweiss A, Beck T, Lorenz R, Friedl TWP, Janni W, Rack B, SUCCESS Study Group. BMC Cancer; 2018 Feb 06; 18(1):141. PubMed ID: 29409452 [Abstract] [Full Text] [Related]
16. Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance). Magbanua MJM, Rugo HS, Wolf DM, Hauranieh L, Roy R, Pendyala P, Sosa EV, Scott JH, Lee JS, Pitcher B, Hyslop T, Barry WT, Isakoff SJ, Dickler M, Van't Veer L, Park JW. Clin Cancer Res; 2018 Mar 15; 24(6):1486-1499. PubMed ID: 29311117 [Abstract] [Full Text] [Related]
18. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients. Markou A, Zavridou M, Sourvinou I, Yousef G, Kounelis S, Malamos N, Georgoulias V, Lianidou E. Clin Chem; 2016 Jul 15; 62(7):1002-11. PubMed ID: 27197674 [Abstract] [Full Text] [Related]